Market LIVE
Published markets; coverage varies by country
Product profile · United States

TRYVIO

 ·  Patent Litigation & Settlement History ↓

IngredientAPROCITENTAN
Application typeNDA
Application217686
Product001
Dosage formTABLET
RouteORAL
Strength12.5MG
Approval date2024-03-19
Marketing statusPrescription
Status event—
ApplicantIDORSIA
Product source

Current GenericRadar decision

Year2029
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typeTRUE_DS_PATENT
Anchor date2029-09-21
Patent anchor2029-09-21
Exclusivity anchor2029-03-22
Protection date2038-07-26
First Final ANDA—
Status event—

ANCHOR_WITH_TAIL; US:NDA:217686:001; exact Final ANDA not verified; not proof of generic absence

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
83242322029-09-21DS/DP/U U-3878YNTRUE_DS
| B1C03 issued-claim review2026-10-15: TRUE_DS
———
83242322029-09-21ORANGE_BOOK U-3878YNTRUE_DS
English description not available.
———
111742472037-11-06U U-3879NNDP
| B1C03 issued-claim review2026-10-15: DP
———
111742472037-11-06ORANGE_BOOK U-3879NNDP
English description not available.
———
109198812038-02-26DS/DP —NNDP
| B1C03 issued-claim review2026-10-15: DP
———
109198812038-02-26ORANGE_BOOK —NNDP
English description not available.
———
122971892038-02-26DP —NNDP
| B1C03 issued-claim review2026-10-15: DP
———
122971892038-02-26ORANGE_BOOK —NNDP
English description not available.
———
117877822038-03-02U U-3877NNDP
| B1C03 issued-claim review2026-10-15: DP
———
117877822038-03-02ORANGE_BOOK U-3877NNDP
English description not available.
———
116800582038-07-26U U-3878NNU
| B1C03 issued-claim review2026-10-15: U
———
116800582038-07-26ORANGE_BOOK U-3878NNU
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2024-03-192029-03-22English description not available.YY2029-03-22—Source
NCE2024-03-192029-03-22English description not available.YY2029-03-22
NCE
Full coverage date: 2029-03-22
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (8)
TypeDateRoleBasisSource
PATENT2029-09-21CANONICAL_ANCHOREnglish description not available.Source
PATENT2037-11-06FTO_TAILEnglish description not available.Source
PATENT2038-02-26FTO_TAILEnglish description not available.Source
PATENT2038-02-26FTO_TAILEnglish description not available.Source
PATENT2038-03-02FTO_TAILEnglish description not available.Source
PATENT2038-07-26FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2029-09-21CANONICAL_DECISIONANCHOR_WITH_TAIL; US:NDA:217686:001; exact Final ANDA not verified; not proof of generic absenceSource
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.